1216 related articles for article (PubMed ID: 29880500)
1. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.
Grebe A; Hoss F; Latz E
Circ Res; 2018 Jun; 122(12):1722-1740. PubMed ID: 29880500
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
[TBL] [Abstract][Full Text] [Related]
3. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition.
Satish M; Agrawal DK
Transl Res; 2020 Jan; 215():75-85. PubMed ID: 31469975
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
6. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 Inflammasome as a Common Denominator of Atherosclerosis and Abdominal Aortic Aneurysm.
Takahashi M
Circ J; 2021 Nov; 85(12):2129-2136. PubMed ID: 33883388
[TBL] [Abstract][Full Text] [Related]
8. The role of the NLRP3 inflammasome in atherosclerotic disease: Systematic review and meta-analysis.
Khair M; Khair M; Vangaveti VN; Malabu UH
J Cardiol; 2024 Jul; 84(1):14-21. PubMed ID: 38521117
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
[TBL] [Abstract][Full Text] [Related]
10. [Advances in mechanisms for NLRP3 inflammasomes regulation].
Liu W; Guo WJ; Xu Q; Sun Y
Yao Xue Xue Bao; 2016 Oct; 51(10):1505-12. PubMed ID: 29924571
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome pathways in atherosclerosis.
Baldrighi M; Mallat Z; Li X
Atherosclerosis; 2017 Dec; 267():127-138. PubMed ID: 29126031
[TBL] [Abstract][Full Text] [Related]
12. Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice.
Zhao J; Wang Z; Yuan Z; Lv S; Su Q
Diab Vasc Dis Res; 2020; 17(6):1479164120977441. PubMed ID: 33269624
[TBL] [Abstract][Full Text] [Related]
13. Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis.
Tumurkhuu G; Shimada K; Dagvadorj J; Crother TR; Zhang W; Luthringer D; Gottlieb RA; Chen S; Arditi M
Circ Res; 2016 Sep; 119(6):e76-90. PubMed ID: 27384322
[TBL] [Abstract][Full Text] [Related]
14. Role of NLRP3 Inflammasomes in Atherosclerosis.
Karasawa T; Takahashi M
J Atheroscler Thromb; 2017 May; 24(5):443-451. PubMed ID: 28260724
[TBL] [Abstract][Full Text] [Related]
15. Probing Inflammasome Activation in Atherosclerosis.
Chan YH; Ramji DP
Methods Mol Biol; 2022; 2419():313-331. PubMed ID: 35237974
[TBL] [Abstract][Full Text] [Related]
16. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F
Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716
[TBL] [Abstract][Full Text] [Related]
17. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S
FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
[TBL] [Abstract][Full Text] [Related]
18. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Duewell P; Kono H; Rayner KJ; Sirois CM; Vladimer G; Bauernfeind FG; Abela GS; Franchi L; Nuñez G; Schnurr M; Espevik T; Lien E; Fitzgerald KA; Rock KL; Moore KJ; Wright SD; Hornung V; Latz E
Nature; 2010 Apr; 464(7293):1357-61. PubMed ID: 20428172
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease.
Ridker PM; Rane M
Circ Res; 2021 May; 128(11):1728-1746. PubMed ID: 33998272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
